Progressive exercise versus best practice advice for adults aged 50 years or over after ankle fracture: the AFTER pilot randomised controlled trial.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
24 11 2022
Historique:
entrez: 24 11 2022
pubmed: 25 11 2022
medline: 29 11 2022
Statut: epublish

Résumé

The aim of the Ankle Fracture Treatment: Enhancing Rehabilitation (AFTER) study, a multicentre external pilot parallel-group randomised controlled trial (RCT), was to assess feasibility of a definitive trial comparing rehabilitation approaches after ankle fracture. Five UK National Health Service hospitals. Participants were aged 50 years and over with an ankle fracture requiring immobilisation for at least 4 weeks. Participants were allocated 1:1 via a central web-based randomisation system to: (1) best practice advice (one session of physiotherapy, up to two optional additional advice sessions) or (2) progressive exercise (up to six sessions of physiotherapy). Feasibility: (1) participation rate, (2) intervention adherence and (3) retention. Sixty-one of 112 (54%) eligible participants participated, exceeding progression criteria for participation of 25%. Recruitment progression criteria was 1.5 participants per site per month and 1.4 was observed. At least one intervention session was delivered for 28/30 (93%) of best practice advice and 28/31 (90%) of progressive exercise participants, exceeding the 85% progression criteria. For those providing follow-up data, the proportion of participants reporting performance of home exercises in the best practice advice and the progressive exercise groups at 3 months was 20/23 (87%) and 21/25 (84%), respectively. Mean time from injury to starting physiotherapy was 74.1 days (95% CI 53.9 to 94.1 days) for the best practice advice and 72.7 days (95% CI 54.7 to 88.9) for the progressive exercise group. Follow-up rate (6-month Olerud and Molander Ankle Score) was 28/30 (93%) for the best practice advice group and 26/31 (84%) in the progressive exercise group with an overall follow-up rate of 89%. This pilot RCT demonstrated that a definitive trial would be feasible. The main issues to address for a definitive trial are intervention modifications to enable earlier provision of rehabilitation and ensuring similar rates of follow-up in each group. ISRCTN16612336.

Identifiants

pubmed: 36424115
pii: bmjopen-2021-059235
doi: 10.1136/bmjopen-2021-059235
pmc: PMC9693648
doi:

Banques de données

ISRCTN
['ISRCTN16612336']

Types de publication

Randomized Controlled Trial Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e059235

Subventions

Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: The institutions of the authors have received research grant funding from National Institute for Health Research, European Union, Royal College of Surgeons England and industry.

Références

Med Sci Sports Exerc. 2002 Feb;34(2):364-80
pubmed: 11828249
BMJ. 2016 Oct 24;355:i5239
pubmed: 27777223
Health Policy. 1996 Jul;37(1):53-72
pubmed: 10158943
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
Arch Phys Med Rehabil. 2002 Jun;83(6):811-5
pubmed: 12048660
J Orthop Sports Phys Ther. 2005 Dec;35(12):786-92
pubmed: 16848099
Acta Bioeng Biomech. 2014;16(4):59-65
pubmed: 25598398
Age Ageing. 2008 Jan;37(1):45-50
pubmed: 18032400
Phys Ther. 1999 Apr;79(4):371-83
pubmed: 10201543
Aust J Physiother. 2009;55(1):31-7
pubmed: 19400023
Aust J Physiother. 1998;44(3):175-180
pubmed: 11676731
BMC Musculoskelet Disord. 2009 Sep 25;10:118
pubmed: 19781053
BMJ. 2010 Mar 23;340:c332
pubmed: 20332509
J Rehabil Med. 2008 Jun;40(6):433-9
pubmed: 18509557
BMC Med Res Methodol. 2010 Jan 06;10:1
pubmed: 20053272
Injury. 2006 Aug;37(8):691-7
pubmed: 16814787
Nurs Res. 2000 May-Jun;49(3):154-9
pubmed: 10882320
Health Technol Assess. 2016 Oct;20(75):1-158
pubmed: 27735787
Bone. 2008 Aug;43(2):340-342
pubmed: 18538645
Cochrane Database Syst Rev. 2012 Nov 14;11:CD005595
pubmed: 23152232
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Osteoporos Int. 2019 Jan;30(1):3-44
pubmed: 30324412
Bone. 2016 Jun;87:19-26
pubmed: 26968752
Value Health. 2012 Jul-Aug;15(5):708-15
pubmed: 22867780
BMJ Open. 2019 Nov 2;9(11):e030877
pubmed: 31678945
JAMA. 2016 Oct 11;316(14):1455-1463
pubmed: 27727383
JAMA. 2015 Oct 6;314(13):1376-85
pubmed: 26441182
Arch Phys Med Rehabil. 2005 Jun;86(6):1118-26
pubmed: 15954049
Sports Med. 2016 Sep;46(9):1311-32
pubmed: 26893098
J Magn Reson Imaging. 2012 Mar;35(3):686-95
pubmed: 22045592
Arch Orthop Trauma Surg (1978). 1984;103(3):190-4
pubmed: 6437370

Auteurs

David J Keene (DJ)

Oxford Trauma and Emergency Care, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK david.keene@ndorms.ox.ac.uk.
Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.

Matthew L Costa (ML)

Oxford Trauma and Emergency Care, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.

Nicholas Peckham (N)

Oxford Clinical Trials Research Unit, University of Oxford, Oxford, UK.

Elizabeth Tutton (E)

Oxford Trauma and Emergency Care, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
Kadoorie Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Vicki S Barber (VS)

Oxford Clinical Trials Research Unit, University of Oxford, Oxford, UK.

Susan J Dutton (SJ)

Oxford Clinical Trials Research Unit, University of Oxford, Oxford, UK.

Sally Hopewell (S)

Oxford Clinical Trials Research Unit, University of Oxford, Oxford, UK.

Anthony C Redmond (AC)

Leeds Institute of Rheumatology and Musculoskeletal Medicine, University of Leeds, Leeds, UK.

Keith Willett (K)

Oxford Trauma and Emergency Care, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.

Sarah E Lamb (SE)

Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.
Oxford Clinical Trials Research Unit, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH